117 related articles for article (PubMed ID: 9857084)
1. A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor.
Parker MA; Marona-Lewicka D; Lucaites VL; Nelson DL; Nichols DE
J Med Chem; 1998 Dec; 41(26):5148-9. PubMed ID: 9857084
[No Abstract] [Full Text] [Related]
2. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and 5-HT2A radioligand receptor binding assays of DOMCl and DOMOM, two novel 5-HT2A receptor ligands.
Harms A; Ulmer E; Kovar KA
Arch Pharm (Weinheim); 2003 Jun; 336(3):155-8. PubMed ID: 12822180
[TBL] [Abstract][Full Text] [Related]
4. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
[TBL] [Abstract][Full Text] [Related]
5. Arylpiperazine derivatives of 3-propyl-beta-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands.
Byrtus H; Pawłowski M; Duszyńska B; Wesołowska A; Chojnacka-Wójcik E; Bojarski AJ
Pol J Pharmacol; 2001; 53(4):395-401. PubMed ID: 11990087
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and serotonin receptor affinities of a series of trans-2-(indol-3-yl)cyclopropylamine derivatives.
Vangveravong S; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
J Med Chem; 1998 Dec; 41(25):4995-5001. PubMed ID: 9836617
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
Chambers JJ; Parrish JC; Jensen NH; Kurrasch-Orbaugh DM; Marona-Lewicka D; Nichols DE
J Med Chem; 2003 Jul; 46(16):3526-35. PubMed ID: 12877591
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
Nelson DL; Lucaites VL; Wainscott DB; Glennon RA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):1-6. PubMed ID: 9933142
[TBL] [Abstract][Full Text] [Related]
9. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship studies of CNS agents, Part 20: 9-(omega-[1-(m-chlorophenyl)-4-piperazinyl]alkyl]-1,2,3,4-tetra-hydro- beta-carbolines: new 5-HT1A and 5-HT2A receptor ligands.
Boksa J; Duszynńska B; Mokrosz JL
Pharmazie; 1995 Mar; 50(3):220-1. PubMed ID: 7732057
[No Abstract] [Full Text] [Related]
11. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
[TBL] [Abstract][Full Text] [Related]
12. Novel pyrimidoazepine analogs as serotonin 5-HT(2A) and 5-HT(2C) receptor ligands for the treatment of obesity.
Yang HY; Tae J; Seo YW; Kim YJ; Im HY; Choi GD; Cho H; Park WK; Kwon OS; Cho YS; Ko M; Jang H; Lee J; Choi K; Kim CH; Lee J; Pae AN
Eur J Med Chem; 2013 May; 63():558-69. PubMed ID: 23537943
[TBL] [Abstract][Full Text] [Related]
13. Serotonin receptor ligands and the treatment of obesity.
Vickers SP; Dourish CT
Curr Opin Investig Drugs; 2004 Apr; 5(4):377-88. PubMed ID: 15134278
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 1,4-disubstituted 2-methylpiperazine derivatives, new 5-HT(1A) receptor ligands.
Cybulski M; Dankiewicz W; Chilmończyk Z
Acta Pol Pharm; 2001; 58(5):357-65. PubMed ID: 11876443
[TBL] [Abstract][Full Text] [Related]
15. 1,2,3,4-tetrahydroisoquinoline derivatives; lipophilicity evaluation vs. 5-HT1A receptor affinity.
Bojarski AJ; Mokrosz MJ
Pharmazie; 1999 Nov; 54(11):828-30. PubMed ID: 10603608
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
[TBL] [Abstract][Full Text] [Related]
17. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors.
Bonhaus DW; Bach C; DeSouza A; Salazar FH; Matsuoka BD; Zuppan P; Chan HW; Eglen RM
Br J Pharmacol; 1995 Jun; 115(4):622-8. PubMed ID: 7582481
[TBL] [Abstract][Full Text] [Related]
18. Identification of a series of benzoxazoles as potent 5-HT6 ligands.
Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
Bioorg Med Chem Lett; 2009 Feb; 19(4):1115-7. PubMed ID: 19152787
[TBL] [Abstract][Full Text] [Related]
19. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dione.
Obniska J; Pawłowski M; Kołaczkowski M; Czopek A; Duszyńska B; Klodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
Pol J Pharmacol; 2003; 55(4):553-7. PubMed ID: 14581713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
